MARSHALL WACE, LLP - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 145 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.3%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$100,109
-65.5%
62,180
-18.8%
0.00%
-100.0%
Q3 2022$290,000
-73.5%
76,606
+0.4%
0.00%
-80.0%
Q1 2021$1,096,000
-91.2%
76,274
-87.9%
0.01%
-92.5%
Q4 2020$12,420,000
+248.9%
632,743
+130.4%
0.07%
+191.3%
Q3 2020$3,560,000
-68.3%
274,670
-64.4%
0.02%
-70.9%
Q2 2020$11,248,000
+1880.3%
771,966
+5295.3%
0.08%
+2533.3%
Q1 2019$568,00014,3080.00%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Antipodean Advisors LLC 1,000,000$1,480,0007.58%
Redmile Group, LLC 6,280,813$9,295,6030.44%
Arctis Global LLC 397,046$587,6280.32%
Baupost Group 9,773,616$14,4650.28%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 230,000$413,4000.24%
MAVERICK CAPITAL LTD 6,290,713$9,310,2550.21%
683 Capital Management, LLC 1,200,000$1,776,0000.14%
STALEY CAPITAL ADVISERS INC 1,000,000$1,480,0000.08%
WASATCH ADVISORS LP 8,399,229$12,430,8590.08%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$777,0000.07%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders